Multi-peptide Vaccine With Basilixumab for Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: BIOLOGICAL: hTERT
Sponsor: Abramson Cancer Center at Penn Medicine